Show Summary Details
Page of

Inflammatory Bowel Disease: Therapy 

Inflammatory Bowel Disease: Therapy
Chapter:
Inflammatory Bowel Disease: Therapy
Author(s):

Darrell S. Pardi

DOI:
10.1093/med/9780199373338.003.0019
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2020. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 26 February 2020

Many therapies are available for patients with inflammatory bowel disease (IBD). Medical therapies include aminosalicylate drugs such as sulfasalazine, olsalazine, balsalazide, and various formulations of mesalamine; antibiotics; corticosteroids; immunosuppressive medications such as azathioprine, 6-mercaptopurine (6-MP), methotrexate, and cyclosporine; and biotechnology medications such as anti–tumor necrosis factor (TNF) agents and newer agents with different mechanisms of action. This chapter reviews these various treatments and their positions in the treatment algorithms for Crohn disease and ulcerative colitis. Many surgical therapies also are used in patients with IBD, although a detailed review of these options is beyond the scope of this chapter.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.